[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"psychooncology\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:psychooncology":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100491468","managing-fear-of-cancer-progression-metacognition-based-vs-supportive-expressive-based-approaches-100491468",false,"NCT05679518","Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches","Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer\n* are the age of 18 years or above\n\nExclusion Criteria:\n\n* Patients with major communication difficulties\n* are being unwilling or unable to commit 6 psychotherapy sessions","ALL","18 Years",{"count":19,"type":20},284,"ESTIMATED","INTERVENTIONAL",[23],"NA","The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.",[26,27,28,29,30],"Advanced or Metastatic Cancer","Fear of Cancer Progression","Metacognition-based Intervention","Supportive-expressive Based Intervention","Psychooncology","RECRUITING","2026-08-11",{"date":34,"type":35},"2026-08-13","ACTUAL",{"date":37,"type":35},"2023-12-20",{"date":39,"type":20},"2027-06-30",{"name":41,"class":42},"The University of Hong Kong","OTHER",4,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},"100531992","e-intervention-on-subclinical-fear-of-cancer-recurrence-100531992","NCT06207006","E-intervention on Subclinical Fear of Cancer Recurrence","Conquering Fear Online: a Pilot Randomised Controlled Trial Assessing the Efficacy and Feasibility of an Internet-based Self-management Intervention on Subclinical Fear of Cancer Recurrence","Inclusion Criteria:\n\n* Cantonese- or Mandarin-speaking Chinese cancer survivors\n* recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer\n* had recently completed surgery as primary treatment\n* have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months\n* scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.\n\nExclusion Criteria:\n\n* non-Chinese ethnicity\n* metastatic cancer\n* with current diagnosis of depression or psychosis or are currently receiving psychological treatments\n* language or intellectual difficulties that prevent them from understanding the intervention content\n* having limited or no Internet access.",{"count":52,"type":20},48,[23],"The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.",[56,30,57],"Cancer","Fear of Cancer Recurrence","2025-10-01",{"date":60,"type":35},"2025-10-03",{"date":62,"type":35},"2024-05-02",{"date":64,"type":20},"2025-12-30",{"name":41,"class":42},1]